 | • レポートコード：MRC2312MG01601 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、66ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の真菌性角膜炎治療市場規模と予測を収録しています。・世界の真菌性角膜炎治療市場：売上、2018年-2023年、2024年-2029年 ・世界の真菌性角膜炎治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の真菌性角膜炎治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 真菌性角膜炎治療のグローバル主要企業は、Novartis AG、 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)、 AbbVie lnc.、 Pfizer lnc.、 Merck and Co. (Merck KGaA)、 Bausch Health Companies Inc.、 Cipla lnc.、 Wellona Pharma、 LEXICARE PHARMA PVT.LTD、 Salvus Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、真菌性角膜炎治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の真菌性角膜炎治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の真菌性角膜炎治療市場：タイプ別市場シェア、2022年 ・錠剤、点眼薬、眼軟膏、結膜下注射 世界の真菌性角膜炎治療市場：用途別、2018年-2023年、2024年-2029年 世界の真菌性角膜炎治療市場：用途別市場シェア、2022年 ・表層角膜炎、深層角膜炎 世界の真菌性角膜炎治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の真菌性角膜炎治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における真菌性角膜炎治療のグローバル売上、2018年-2023年 ・主要企業における真菌性角膜炎治療のグローバル売上シェア、2022年 ・主要企業における真菌性角膜炎治療のグローバル販売量、2018年-2023年 ・主要企業における真菌性角膜炎治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis AG、 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)、 AbbVie lnc.、 Pfizer lnc.、 Merck and Co. (Merck KGaA)、 Bausch Health Companies Inc.、 Cipla lnc.、 Wellona Pharma、 LEXICARE PHARMA PVT.LTD、 Salvus Pharma ************************************************************* ・調査・分析レポートの概要 真菌性角膜炎治療市場の定義 市場セグメント 世界の真菌性角膜炎治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の真菌性角膜炎治療市場規模 世界の真菌性角膜炎治療市場規模：2022年 VS 2029年 世界の真菌性角膜炎治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの真菌性角膜炎治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の真菌性角膜炎治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：錠剤、点眼薬、眼軟膏、結膜下注射 真菌性角膜炎治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：表層角膜炎、深層角膜炎 真菌性角膜炎治療の用途別グローバル売上・予測 ・地域別市場分析 地域別真菌性角膜炎治療市場規模 2022年と2029年 地域別真菌性角膜炎治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis AG、 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)、 AbbVie lnc.、 Pfizer lnc.、 Merck and Co. (Merck KGaA)、 Bausch Health Companies Inc.、 Cipla lnc.、 Wellona Pharma、 LEXICARE PHARMA PVT.LTD、 Salvus Pharma ... |
This research report provides a comprehensive analysis of the Fungal Keratitis Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fungal Keratitis Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fungal Keratitis Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Fungal Keratitis Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fungal Keratitis Treatment market presents opportunities for various stakeholders, including Superficial Keratitis, Deep Keratitis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fungal Keratitis Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fungal Keratitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Fungal Keratitis Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fungal Keratitis Treatment market.
Market Overview: The report provides a comprehensive overview of the Fungal Keratitis Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tablets, Eye Drops), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fungal Keratitis Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fungal Keratitis Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fungal Keratitis Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fungal Keratitis Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fungal Keratitis Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fungal Keratitis Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fungal Keratitis Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fungal Keratitis Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fungal Keratitis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tablets
Eye Drops
Ophthalmic Ointments
Subconjunctival lnjections
Market segment by Application
Superficial Keratitis
Deep Keratitis
Global Fungal Keratitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis AG
Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)
AbbVie lnc.
Pfizer lnc.
Merck and Co. (Merck KGaA)
Bausch Health Companies Inc.
Cipla lnc.
Wellona Pharma
LEXICARE PHARMA PVT.LTD
Salvus Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fungal Keratitis Treatment, market overview.
Chapter 2: Global Fungal Keratitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Fungal Keratitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fungal Keratitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fungal Keratitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fungal Keratitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fungal Keratitis Treatment Overall Market Size
2.1 Global Fungal Keratitis Treatment Market Size: 2022 VS 2029
2.2 Global Fungal Keratitis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fungal Keratitis Treatment Players in Global Market
3.2 Top Global Fungal Keratitis Treatment Companies Ranked by Revenue
3.3 Global Fungal Keratitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Fungal Keratitis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fungal Keratitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fungal Keratitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Fungal Keratitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Fungal Keratitis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Fungal Keratitis Treatment Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Eye Drops
4.1.4 Ophthalmic Ointments
4.1.5 Subconjunctival lnjections
4.2 By Type – Global Fungal Keratitis Treatment Revenue & Forecasts
4.2.1 By Type – Global Fungal Keratitis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Fungal Keratitis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Fungal Keratitis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fungal Keratitis Treatment Market Size, 2022 & 2029
5.1.2 Superficial Keratitis
5.1.3 Deep Keratitis
5.2 By Application – Global Fungal Keratitis Treatment Revenue & Forecasts
5.2.1 By Application – Global Fungal Keratitis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Fungal Keratitis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Fungal Keratitis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Fungal Keratitis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Fungal Keratitis Treatment Revenue & Forecasts
6.2.1 By Region – Global Fungal Keratitis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Fungal Keratitis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Fungal Keratitis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Fungal Keratitis Treatment Revenue, 2018-2029
6.3.2 US Fungal Keratitis Treatment Market Size, 2018-2029
6.3.3 Canada Fungal Keratitis Treatment Market Size, 2018-2029
6.3.4 Mexico Fungal Keratitis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Fungal Keratitis Treatment Revenue, 2018-2029
6.4.2 Germany Fungal Keratitis Treatment Market Size, 2018-2029
6.4.3 France Fungal Keratitis Treatment Market Size, 2018-2029
6.4.4 U.K. Fungal Keratitis Treatment Market Size, 2018-2029
6.4.5 Italy Fungal Keratitis Treatment Market Size, 2018-2029
6.4.6 Russia Fungal Keratitis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Fungal Keratitis Treatment Market Size, 2018-2029
6.4.8 Benelux Fungal Keratitis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Fungal Keratitis Treatment Revenue, 2018-2029
6.5.2 China Fungal Keratitis Treatment Market Size, 2018-2029
6.5.3 Japan Fungal Keratitis Treatment Market Size, 2018-2029
6.5.4 South Korea Fungal Keratitis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Fungal Keratitis Treatment Market Size, 2018-2029
6.5.6 India Fungal Keratitis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Fungal Keratitis Treatment Revenue, 2018-2029
6.6.2 Brazil Fungal Keratitis Treatment Market Size, 2018-2029
6.6.3 Argentina Fungal Keratitis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Fungal Keratitis Treatment Revenue, 2018-2029
6.7.2 Turkey Fungal Keratitis Treatment Market Size, 2018-2029
6.7.3 Israel Fungal Keratitis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Fungal Keratitis Treatment Market Size, 2018-2029
6.7.5 UAE Fungal Keratitis Treatment Market Size, 2018-2029
7 Fungal Keratitis Treatment Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Fungal Keratitis Treatment Major Product Offerings
7.1.4 Novartis AG Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)
7.2.1 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.) Company Summary
7.2.2 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.) Business Overview
7.2.3 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.) Fungal Keratitis Treatment Major Product Offerings
7.2.4 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.) Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.2.5 Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.) Key News & Latest Developments
7.3 AbbVie lnc.
7.3.1 AbbVie lnc. Company Summary
7.3.2 AbbVie lnc. Business Overview
7.3.3 AbbVie lnc. Fungal Keratitis Treatment Major Product Offerings
7.3.4 AbbVie lnc. Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.3.5 AbbVie lnc. Key News & Latest Developments
7.4 Pfizer lnc.
7.4.1 Pfizer lnc. Company Summary
7.4.2 Pfizer lnc. Business Overview
7.4.3 Pfizer lnc. Fungal Keratitis Treatment Major Product Offerings
7.4.4 Pfizer lnc. Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.4.5 Pfizer lnc. Key News & Latest Developments
7.5 Merck and Co. (Merck KGaA)
7.5.1 Merck and Co. (Merck KGaA) Company Summary
7.5.2 Merck and Co. (Merck KGaA) Business Overview
7.5.3 Merck and Co. (Merck KGaA) Fungal Keratitis Treatment Major Product Offerings
7.5.4 Merck and Co. (Merck KGaA) Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.5.5 Merck and Co. (Merck KGaA) Key News & Latest Developments
7.6 Bausch Health Companies Inc.
7.6.1 Bausch Health Companies Inc. Company Summary
7.6.2 Bausch Health Companies Inc. Business Overview
7.6.3 Bausch Health Companies Inc. Fungal Keratitis Treatment Major Product Offerings
7.6.4 Bausch Health Companies Inc. Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.6.5 Bausch Health Companies Inc. Key News & Latest Developments
7.7 Cipla lnc.
7.7.1 Cipla lnc. Company Summary
7.7.2 Cipla lnc. Business Overview
7.7.3 Cipla lnc. Fungal Keratitis Treatment Major Product Offerings
7.7.4 Cipla lnc. Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.7.5 Cipla lnc. Key News & Latest Developments
7.8 Wellona Pharma
7.8.1 Wellona Pharma Company Summary
7.8.2 Wellona Pharma Business Overview
7.8.3 Wellona Pharma Fungal Keratitis Treatment Major Product Offerings
7.8.4 Wellona Pharma Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.8.5 Wellona Pharma Key News & Latest Developments
7.9 LEXICARE PHARMA PVT.LTD
7.9.1 LEXICARE PHARMA PVT.LTD Company Summary
7.9.2 LEXICARE PHARMA PVT.LTD Business Overview
7.9.3 LEXICARE PHARMA PVT.LTD Fungal Keratitis Treatment Major Product Offerings
7.9.4 LEXICARE PHARMA PVT.LTD Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.9.5 LEXICARE PHARMA PVT.LTD Key News & Latest Developments
7.10 Salvus Pharma
7.10.1 Salvus Pharma Company Summary
7.10.2 Salvus Pharma Business Overview
7.10.3 Salvus Pharma Fungal Keratitis Treatment Major Product Offerings
7.10.4 Salvus Pharma Fungal Keratitis Treatment Revenue in Global Market (2018-2023)
7.10.5 Salvus Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer